Elsevier

Gynecologic Oncology

Volume 19, Issue 3, November 1984, Pages 329-335
Gynecologic Oncology

Synchronous carcinomas of the uterine corpus and ovary

https://doi.org/10.1016/0090-8258(84)90200-2Get rights and content

Abstract

The coexistence of carcinoma in the endometrium and ovary is a relatively uncommon but not rare occurrence. In general it has not been possible to determine which, if any, of these tumors represent metastases from endometrium or ovary or separate primary neoplasms, and gynecologists are unable to agree upon appropriate therapy. Twenty-four women with synchronous carcinomas of the ovary and endometrium in whom disease was confined to the pelvis, diagnosed at the Milton S. Hershey Medical Center between 1970 and 1982, were identified. Thirteen women had typical endometrial adenocarcinoma and endometrioid carcinoma of the ovary (Group A), two had unusual variants of endometrial carcinoma and a similar appearing tumor in the ovary (Group B), and nine had typical endometrial adenocarcinoma with carcinomas in the ovary of differing histologic appearance (Group C). There was no significant difference in survival between women in Groups A and C (77 and 56%, respectively, mean follow-up approximately 40 months). However, deep myometrial invasion (outer third) provided a statistically significant indicator of poor prognosis (77% with deep invasion vs 17% with superficial invasion recurred or died of disease P < 0.05, χ2test).

References (12)

  • E.W. Munnell et al.

    Ovarian carcinoma

    Amer. J. Obstet. Gynecol.

    (1949)
  • D.L. Matlock et al.

    Synchronous multiple neoplasms of the upper female genital tract

    Gynecol. Oncol.

    (1982)
  • H.L. Kottmeier
  • E.F. Schueller et al.

    Prognosis in endometrioid carcinoma of the ovary

    Obstet. Gynecol.

    (1966)
  • M.B. Dockerty

    Primary and secondary ovarian adenocanthoma

    Surg. Gynecol. Obstet.

    (1954)
  • R.J. Kurman et al.

    Endometrioid and clear cell carcinoma of the ovary

    Cancer

    (1972)
There are more references available in the full text version of this article.

Cited by (93)

  • Adenocarcinoma of the uterine corpus and sarcomas of the uterus

    2023, DiSaia and Creasman Clinical Gynecologic Oncology
  • Risk-based stratification of carcinomas concurrently involving the endometrium and ovary

    2019, Gynecologic Oncology
    Citation Excerpt :

    In our study, women with ENECs had poorer PFS than those with EECs, and endometrial histology (EEC vs. ENEC) and lymph node status were associated with clinical outcomes in multivariable analysis. Tumor histotype was not associated with clinical outcomes in some studies [1,18,26,28]. However, an earlier study by Eifel et al. showed that 55% (6/11) of women with ENECs died of disease compared to none of the 16 women with EECs [17].

  • Adenocarcinoma of the uterine corpus

    2018, Clinical Gynecologic Oncology
  • Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes

    2016, Surgical Pathology Clinics
    Citation Excerpt :

    Women with EC may be asymptomatic whereas others present with symptoms related to their pelvic mass. Endometrial carcinoma occurs concurrently in 20% or more of the cases of ovarian EC.38–40 EC arises from endometriosis that has undergone hyperplasia and changes that are morphologically indistinguishable from atypical hyperplasia of eutopic endometrium.

  • Incidence and factors associated with synchronous ovarian and endometrial cancer: A population-based case-control study

    2012, Gynecologic Oncology
    Citation Excerpt :

    Histologic criteria for the diagnosis of synchronous EC/OC were originally proposed by Scully et al., and updated by Ulbright and Roth [1,7,8]. They defined the most contemporary diagnosis of synchronous EC/OC, which requires the absence of multinodular ovarian pattern (major criterion) or two or more of the following minor criteria: absent deep myometrial invasion, unilateral ovarian involvement, absent lymphovascular invasion, lack of tubal lumen involvement, and an enlarged ovary (> 5 cm) [1,7-10]. It has been previously reported that synchronous EC/OC cases are more prevalent in younger (median age 41–52 years), obese, premenopausal and nulliparous women [1,7,8,10-12].

View all citing articles on Scopus
View full text